IRS1 and non-small cell lung carcinoma: Our data provide rationale for continued study of the mechanisms by which IRS-1 and IRS-2 contribute to NSCLC and for further validation of the predictive value of the relative levels of IRS-1 and IRS-2 expression for NSCLC outcomes.